Drug Shortage Report for LIORESAL INTRATHECAL 0.5MG/ML

Last updated on 2022-01-17 History
Report ID 148466
Drug Identification Number 02131056
Brand name LIORESAL INTRATHECAL 0.5MG/ML
Common or Proper name LIORESAL 10MG/20ML 1X1 AMPS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BACLOFEN
Strength(s) 0.5MG
Dosage form(s) SOLUTION
Route of administration INTRATHECAL INTRATHECAL
Packaging size 1 X 1 AMPS
ATC code M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-11-05
Actual start date
Estimated end date Unknown
Actual end date 2021-11-11
Shortage status Resolved
Updated date 2022-01-17
Company comments Delay in product release
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-01-17 French Compare
v4 2022-01-17 English Compare
v3 2021-11-06 English Compare
v2 2021-10-28 French Compare
v1 2021-10-28 English Compare

Showing 1 to 5 of 5